Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptide JT3002

Cancer Biotherapy and Radiopharmaceuticals

Volumn 12, Issue 5, 1997, Pages 333-340

  Kumar, Rakesh ^a   Eue, Ines ^a   Dong, Zhongyun ^a   Killion, Jerald J ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cytokines; Lipopeptide JT3002; Macrophages

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LIPOPROTEIN; OUTER MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CYTOLYSIS; DOSE TIME EFFECT RELATION; FEMALE; GRAM NEGATIVE BACTERIUM; IMMUNOSTIMULATION; INTERFERON PRODUCTION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

EID: 0031441681     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1997.12.333     Document Type: Article

References (37)

1. Fidler IJ. Therapy of cancer metastasis by systemic activation of macrophages. Adv Pharmacol 1994;30: 271-326.
2. Varesio L, Blasi E, Thurman GB, Talmadge JE, Elitrout RH, Herberman RB. Potent activation of mouse macrophages by recombinant interferon-γ. Cancer Res 1984; 44:4465-4469.
3. Saiki I, Fidler IJ. Synergistic activation of recombinant mouse IFN-γ and muramyl dipeptide of tumoricidal properties in mouse macrophages. J Immunol 1985; 135:684-688.
4. Hori K, Mihich E, Ehrke MJ Role of tumor necrosis factor and interleukin-1 in γ-interferon-promoted activation of mouse tumoricidal macrophages. Cancer Res 1989,49:2606-2614.
5. Mace KF, Ehrke MJ, Hori K, Maccubbin DL, Mihich E. Role of tumor necrosis factor in macrophage activation and tumoricidal activity. Cancer Res 1988; 48:5427-5432.
6. Sampson-Johannes A, Carlino JA. Enhancement of human monocyte tumoricidal activity by recombinant macrophage colony stimulating factor. J Immunol 1988; 141:3680-3686.
7. Singh RK, Berry KK, Matsushima K, Mukaida N, Fidler IJ. Synergism between monocyte chemotactic and activating factor (MCAF) and bacterial products in murine macrophages. J Immunol 1993;151:2786-2793.
8. Asano T, Kleinerman ES. Liposome-encapsulated MTP-PE: a novel biological agent for cancer therapy. J Immunother 1993;14:268-292.
9. Koff WC, Fidler IJ The potential use of liposome-mediated antiviral therapy. J Antiviral Res 1985; 228:495-497
10. MacEwen EG, Kurzman ID, Rosenthal RC, Smith BW, Manley PA, Roush JK, Howar PE. Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide. J Natl Cancer Inst 1989;81:935-938.
11. MacEwen EG, Kurzman ID, Helfand S, Vail D, London C, Kisseberth W, Rosenthal RC, Fox LE, Keller ET, Obradovich J. Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors. A progressive review. J Drug Targeting 1994;2:391-396.
12. Kleinerman ES, Fidler D. Systemic activation of macrophages by liposomes containing immunomodulators. In: Hellman S, De Vita VT, Rosenberg SA (eds), Biologic Therapy of Cancer: Principles and Practice, 2nd edt. Philadelphia: Lippincott, 1995;829-839.
13. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;78:319-330.
14. 2 by human blood monocytes subsequent to interaction with different bacterial derived agents. Lymphokine Res 1990;9:449-454.
15. Utsugi T, Nii A, Fan D, Pak CC, Denkins Y, van Hoogevest P, Fidler IJ. Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages. Cancer Immunol Immunother 1991;33:285-292.
16. Utsugi T, Dinney CPN, Killion JJ, Fidler IJ. In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP31362. Cancer Immunol Immunother 1991;33:375-381.
17. Nii A, Utsugi T, Fan D, Denkins Y, Pak C, Brown D, van Hoogevest P, Fidler IJ. Optimization of the liposomes encapsulating a new lipopeptide CGP 31362 for efficient activation of tumoricidal properties in monocytes and macrophages. J Immunother 1991;10: 236-246.
18. van Hoogevest P, Fankhauser P. An industrial liposomal dosage form for muramyl tripeptide phosphatidylethanolamine (MTP-PE). In Lopez-Berestein G and Fidler IJ, eds. Liposomes in the therapy of infectious diseases and cancer. Liss, New York, 1989;453-466.
19. Schroit AJ, Fidler IJ. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res 1982;42:161-167.
20. Dong Z, O'Brian CA, Fidler IJ. Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein tyrosine kinase activity. J Leukoc Biol 1993;53:53-60.
21. Dong Z, Qi X, Fidler IJ. Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. J Exp Med 1993;177:1071-1077.
22. Ding AE, Sanchez E, Nathan CF. Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J Immunol 1993;151:5596-5602.
23. Kumar R, Dong Z, Fidler IJ. Differential regulation of metalloelastase activity in murine macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony stimulating factor. J Immunol 1996; 157:5104-5111.
24. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 1990;249:1431-1439.
25. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobia PS, Ulevitch RJ. Structure and function of lipopolysaccharide-binding protein. Science 1990;249:1429-1431.
26. Weinstein SL, Sanghera JS, Lemke K, Defranco AL, Pelech SL. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kineses in macrophages. J Biol Chem 1992;267:14955-14962.
27. Arditi M, Zhou J, Torres M, Durden DL, Stins M, Kim KS. Lipopolysaccharide stimulates tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner. Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells. J Immunol 1995;155:3993-4003.
28. Liu MK, Herrera-Velit P, Brownsey RW, Reiner NE. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J Immunol 1994;153:2642-2652.
29. Paul A, Pendreigh RH, Plevin R. Protein kinase C and tyrosine kinase pathways regulate lipopolysaccharide-induced nitric oxide synthase activity in RAW 264.7 murine macrophages. Br J Pharmacol 1995;114:482-488.
30. Shinji H, Akagawa KS, Yoshida T. LPS induces selective translocation of protein kinase C-β in LPS-responsive mouse macrophages but not in LPS-nonresponsive mouse macrophages. J Immunol 1994;153: 5760-5771.
31. Novotney M, Chang ZL, Uchiyama H, Suzuki T. Protein kinase C in tumoricidal activation of mouse macrophage cell lines. Biochemistry 1991;30:5597-5604.
32. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995;92:7686-7689.
33. Constantinou A, Huberman E. Genistein as an inducer of tumor cell differentiation: possible mechanisms of actions. Proc Soc Exp Biol Med 1995;208:109-115.
34. Jarvis WD, Turner AJ, Povirk LF, Taylor RS, Grant S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res 1994;54:1707-1714.
35. Findik D, Song Q, Hidaka H, Lavin M. Protein kinase A inhibitors enhance radiation-induced apoptosis. J Cell Biochem 1995;57:12-21
36. Fidler IJ. Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res 1985;45:4714-26
37. Celada A, Schreiber RD. Role of protein kinase C and intracellular calcium mobilization in the induction of macrophage tumoricidal activity by interferon-gamma. J Immunol 1986;137:2373-2379.